Kymab
Discovers and develops human antibody therapeutics
Kymab has raised €98M across 3 funding rounds from 1 investor, most recently a Series B round in May 2015. Based in Cambridge, UK; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€98M
€98,237,871
Funding rounds
3
Investors
1
distinct backers
Active since
2010-07
latest 2015-05
Funding by year
EUR raised per yearKymab — funding by year — interactive chart.
Data table
| Kymab — funding by year | |
|---|---|
| 2010 | €25M |
| 2014 | €29M |
| 2015 | €45M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (17y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-05-01 | Series B | €45M | Woodford Investment Management | View deal → |
| 2014-05-01 | Series B | €29M | — | View deal → |
| 2010-07-01 | Series A | €25M | — | View deal → |